Skip to content

HUMAN GENOME SCIENCES INC

Delisted

CIK 901219fmd_0X02H4B0ZBMN85JBQ7JXCZVJQGManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2009 to Jun 30, 2012, 11 periods

Latest annual · FY2011

Millions
Total revenues
131
Gross profit
84
Operating income
(330)
Net income
(381)
Free cash flow
(417)

Latest quarter · Q2 FY2012

Millions
Total revenues
60
Gross profit
52
Operating income
(75)
Net income
(93)
Free cash flow
(51)
Open Financials

HUMAN GENOME SCIENCES INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2011FY2010ChangeSource
Revenue$131 million$157.4 million-16.8%10-K 2012-02-28 · proof
Gross profit$83.9 million$127.4 million-34.1%10-K 2012-02-28 · proof
Operating income-$329.6 million-$190.8 million10-K 2012-02-28 · proof
Net income-$381.1 million-$233.2 million10-K 2012-02-28 · proof
Cash from operating activities-$397.9 million-$280.7 million10-K 2012-02-28 · proof
Free cash flow-$416.9 million-$290.5 million10-K 2012-02-28 · proof
Total assets$1.4 billion$1.3 billion+7%10-K 2012-02-28 · proof
Total liabilities$951.2 million$729.3 million+30.4%10-K 2012-02-28 · proof
Cash and cash equivalents$402 million$155.7 million+158.2%10-K 2012-02-28 · proof
Total debt$813.8 million$623.4 million+30.6%10-K 2012-02-28 · proof
What was HUMAN GENOME SCIENCES INC's revenue in fiscal 2011?
HUMAN GENOME SCIENCES INC reported revenue of $131 million for fiscal 2011 (the year ended Dec 31, 2011), against $157.4 million the year before (-16.8%). Source: the 10-K filed with the SEC on Feb 28, 2012. SEC
What was HUMAN GENOME SCIENCES INC's gross profit in fiscal 2011?
HUMAN GENOME SCIENCES INC reported gross profit of $83.9 million for fiscal 2011 (the year ended Dec 31, 2011), against $127.4 million the year before (-34.1%). Source: the 10-K filed with the SEC on Feb 28, 2012. SEC
What was HUMAN GENOME SCIENCES INC's operating income in fiscal 2011?
HUMAN GENOME SCIENCES INC reported operating income of -$329.6 million for fiscal 2011 (the year ended Dec 31, 2011), against -$190.8 million the year before. Source: the 10-K filed with the SEC on Feb 28, 2012. SEC
What was HUMAN GENOME SCIENCES INC's net income in fiscal 2011?
HUMAN GENOME SCIENCES INC reported net income of -$381.1 million for fiscal 2011 (the year ended Dec 31, 2011), against -$233.2 million the year before. Source: the 10-K filed with the SEC on Feb 28, 2012. SEC
What was HUMAN GENOME SCIENCES INC's cash from operating activities in fiscal 2011?
HUMAN GENOME SCIENCES INC reported cash from operating activities of -$397.9 million for fiscal 2011 (the year ended Dec 31, 2011), against -$280.7 million the year before. Source: the 10-K filed with the SEC on Feb 28, 2012. SEC
What was HUMAN GENOME SCIENCES INC's free cash flow in fiscal 2011?
HUMAN GENOME SCIENCES INC reported free cash flow of -$416.9 million for fiscal 2011 (the year ended Dec 31, 2011), against -$290.5 million the year before. Source: the 10-K filed with the SEC on Feb 28, 2012. SEC
What are HUMAN GENOME SCIENCES INC's total assets?
As of Dec 31, 2011, HUMAN GENOME SCIENCES INC reported total assets of $1.4 billion, against $1.3 billion a year earlier (+7%). Source: the 10-K filed with the SEC on Feb 28, 2012. SEC
What are HUMAN GENOME SCIENCES INC's total liabilities?
As of Dec 31, 2011, HUMAN GENOME SCIENCES INC reported total liabilities of $951.2 million, against $729.3 million a year earlier (+30.4%). Source: the 10-K filed with the SEC on Feb 28, 2012. SEC
What are HUMAN GENOME SCIENCES INC's cash and cash equivalents?
As of Dec 31, 2011, HUMAN GENOME SCIENCES INC reported cash and cash equivalents of $402 million, against $155.7 million a year earlier (+158.2%). Source: the 10-K filed with the SEC on Feb 28, 2012. SEC
What is HUMAN GENOME SCIENCES INC's total debt?
As of Dec 31, 2011, HUMAN GENOME SCIENCES INC reported total debt of $813.8 million, against $623.4 million a year earlier (+30.6%). Source: the 10-K filed with the SEC on Feb 28, 2012. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:901219&period_type=annual&limit=5"

Information only, not investment advice.